Journal profile · Medicine-Rheumatology
Archives of Rheumatology
ISSN 2618-6500 · Baycinar Medical Publishing · Turkey · Quarterly · Founded 2014
Archives of Rheumatology: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.27; fully open access; median 95 days to acceptance (15 articles, last 24 months); 59 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Archives of Rheumatology is published by Baycinar Medical Publishing and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Rheumatoid Arthritis Research and Therapies, Spondyloarthritis Studies and Treatments and Systemic Lupus Erythematosus Research, together about 36.1% of its articles. Its main subfields are Rheumatology. (generated from OpenAlex topic counts and CAS ranking data)
Publishes high-impact scientific papers in rheumatology. International independent peer review standards and open-access model ensure research reaches a wide scientific audience.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Rheumatology
Editor-in-chief Meltem ALKANPublisher website
Editorial board by country: none in mainland China; most named Türkiye 33, United States 4, India 3, Italy 3, Germany 2 (62 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Rheumatoid Arthritis Research and TherapiesMedicine16.6%
- Spondyloarthritis Studies and TreatmentsMedicine11.5%
- Systemic Lupus Erythematosus ResearchMedicine8.1%
- Fibromyalgia and Chronic Fatigue Syndrome ResearchMedicine5.8%
- Systemic Sclerosis and Related DiseasesMedicine5.6%
- Autoimmune and Inflammatory Disorders ResearchMedicine5%
- Inflammasome and immune disordersBiochemistry, Genetics and Molecular Biology4.9%
- Vasculitis and related conditionsMedicine4.9%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Rheumatology | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
PubMedPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.27LetPub ·
- Impact factor (publisher)
- 1.3Publisher website ·
- CiteScore 2026-06
- 2.3LetPub ·
- CiteScore (publisher)
- 2.3Publisher website ·
- SJR 2026-06
- 0.45LetPub ·
- SNIP 2026-06
- 0.53LetPub ·
- h-index
- 10LetPub ·
- h-index
- 32OpenAlex ·
- i10-index
- 232OpenAlex ·
- 2-year mean citedness
- 1.89OpenAlex ·
- Self-citation rate
- 7.7%LetPub ·
- Share of gold OA articles
- 98.83%LetPub ·
Volume
- Articles per year
- 50LetPub ·
Articles by year OpenAlex count · 1,157 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 54 | 54 | 7 |
| 2025 | 59 | 59 | 105 |
| 2024 | 78 | 78 | 249 |
| 2023 | 78 | 78 | 284 |
| 2022 | 39 | 39 | 217 |
| 2021 | 107 | 107 | 791 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
95 daysMedian, submission to acceptance · P25–P75 78 days – 140 days
- Acceptance to online
- median 60 days (15 articles)
- Submission to online
- median 166 days
- Sample
- 15 articles with submission and acceptance dates (108 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 28 daysPublisher website ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Policy excerpts from the journal's websitePeer review
- Peer review
Peer review, open access, online-only journal published by TLAR. Model summary
Archives of Rheumatology is a peer reviewed, open access, online-only journal published by the Turkish League Against Rheumatism (TLAR).
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Baycinar Medical Publishing
- Country or region
- Turkey
- Language
- English
- Frequency
- Quarterly
- Founded
- 2014
- ISSN
- 2618-6500
- Print ISSN
- 1309-0283
- Society / sponsor
- Turkish League Against Rheumatism
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about Archives of Rheumatology
What CAS zone is Archives of Rheumatology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Archives of Rheumatology is in Zone 4 of Medicine, and in Zone 4 of the minor category Rheumatology. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Archives of Rheumatology?
The latest impact factor listed by LetPub is 1.27; CiteScore 2.3, h-index 32.
How long does peer review take at Archives of Rheumatology?
Based on the dates recorded on 15 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 95 days (interquartile range 78–140 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Archives of Rheumatology based?
Of the 62 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Türkiye (33), United States (4) and India (3). Counted from the institutions listed on the board page; for reference only.
Which databases index Archives of Rheumatology?
According to LetPub and DOAJ records, Archives of Rheumatology is indexed in SCIE and Scopus. The journal's website also lists PubMed; that list has not been checked against each database.
Is Archives of Rheumatology open access, and what is the APC?
Archives of Rheumatology is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .